Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GDC Holdings is a private healthcare holding company focused on dental laboratory products and services through National Dentex Labs (NDX). The business operates a large North American network of dental laboratories providing crowns, bridges, dentures, implants, orthodontic appliances, and related restorative offerings. Public reporting and company materials indicate that GDC has expanded through acquisitions, including the 2018 acquisition of Trident Dental Laboratories, and has invested in digital dentistry and surgical-planning capabilities. The company appears to be a commercial-stage dental services and products organization rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GDC Holdings.